Getting Ahead of the Game in Cell and Gene Therapy
March 12, 2020 - Cytiva

Cytiva and GoSilico Agree to Co-market ChromXâ„¢ Mechanistic Mode


March 12, 2020 - Cytiva

The agreement facilitates the adoption of

The Evolution of Supply Chain Security: Increasing Focus on Raw M


March 12, 2020 - Cytiva

An increase in the development of biological and patient-speci

Flexible Facilities for Viral Vector Manufacturing
March 12, 2020 - BioPharm International

Improving Upstream Predictability
March 12, 2020 - BioPharm International

Introducing Process Characterization Kit: New Tools for Gaining D


February 27, 2020 - Cytiva

Study the potential impact of resin ligand density on process outcome with Process Characterization Kits. The kits provide critical insights on resin variation

Mechanistic Modeling of Chromatography: Opportunities and Challen


February 27, 2020 - Cytiva

What is mechanistic modeling in chromatography? Explore opportunities and challenges of an approach that can help make process development become faster, more s

Epitope Binning: A Critical Step in Antibody Selection
February 27, 2020 - Cytiva

Read about how surface plasmon resonance (SPR) is used to characterize closely related “bins” of monoclonal antibodies (mAbs) targeting the same epitope of

Maximizing the Effectiveness of Upstream Bioprocessing Through th


February 27, 2020 - BioPharm International

By establishing effective management of data and knowledge, it will be possible to employ advances, such as artificial intelligence and synthetic biolog

Purification of Plasmid DNA
February 13, 2020 - Cytiva

Plasmid DNA is the building block of advanced therapies. As these thera

Previous PageNext Page